Added to YB: 2021-05-05
Pitch date: 2021-05-05
NBSE [bullish]
NeuBase Therapeutics, Inc.
-99.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes.
Market Cap
EUR 1.4M
Pitch Price
EUR 94.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.02
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
NEUBASE THERAPEUTICS INC NBSE
A summary for this pitch has not been created yet.
Read full article (0 min)